GlassScriptPhysician profile
Jacqueline Rubinstein
NPI 1174108039
$2,783.56
in general payments reported to CMS, 2019-2025
23 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,332 · 2024: $964 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,774.56 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $692.86 | 2023-2025 | Lokelma, Farxiga |
| Amgen INC. | $385.35 | 2023-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $297.99 | 2023 | Optimizer |
| Cvrx, INC. | $217.33 | 2024 | Barostim Neo System |
| Boston Scientific Corporation | $198.67 | 2024 | Watchman Access System, Versacross Large Access Solution |
| Edwards Lifesciences Corporation | $135.56 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien Xt Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $121.26 | 2023-2025 | Lifevest |
| Medtronic, INC. | $118.84 | 2023 | Micra |
| Genzyme Corporation | $102.00 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $95.72 | 2023 | Inpefa |
| Novartis Pharmaceuticals Corporation | $74.48 | 2024-2025 | |
| Abiomed | $71.68 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $44.56 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $30.33 | 2025 | Evkeeza |
| E.R. Squibb & Sons, L.L.C. | $28.63 | 2023 | Eliquis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $26.75 | 2025 | Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $25.90 | 2025 | |
| Teleflex LLC | $22.46 | 2023 | Vascband |
| Merck Sharp & Dohme LLC | $21.97 | 2023 | Verquvo |
| Heartflow, INC. | $21.49 | 2025 | |
| Pfizer INC. | $19.45 | 2023 | |
| Bridgebio Pharma, INC. | $16.47 | 2025 | Attruby |
| Irhythm Technologies, INC. | $13.81 | 2024 | Zio Monitor, Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Rubinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.